Clinical Trial

InsightRP2 Registry

Recruiting
View on ClinicalTrials.gov →
Summary
InsightRP2 is a secure online patient registry specific to RP2-associated retinitis pigmentosa (RP). It is our goal to further the scientific understanding of this rare disease and to support research in to a gene therapy for RP2-associated RP. We collect medical, genetic and imaging data from people affected by RP2-associated RP and will coduct a natural history study as well as image analysis studies.
Trial Details
NCT Number NCT06982417
Lead Sponsor University of Göttingen
Conditions RP2-associated Retinitis Pigmentosa, X-Linked Retinitis Pigmentosa (XLRP), Retinitis Pigmentosa 2
Enrollment 200 participants
Start Date 2025-05-01
Primary Completion 2045-05-01 (estimated)
Study Completion 2045-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-21